We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Biomarker-based Companion Diagnostics Are Enabling Precision Oncology

Video   Sep 17, 2019 | by OriGene Technologies Inc.

 

Clinical trials are underway to examine the efficacy of various immune checkpoint inhibitor molecules, for the treatment of cancer.

Watch this video to learn about the companion diagnostics that are enabling the identification of patients who could benefit from these treatments.

 
More Information
 
 
Advertisement
 

Recommended Videos

Teach Me in 10 – Organs-on-a-Chip With Dr Ali Khademhosseini

Video

In this installment of Teach Me in 10 we're joined by the renowned scientist Dr Ali Khademhosseini, director and CEO of the Terasaki Institute.

WATCH NOW

Giant Spider Provides Promise of Pain Relief for Irritable Bowel Syndrome

Video

Molecules from the venom of one of the world’s largest spiders could help researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

WATCH NOW

Duchenne Muscular Dystrophy and Gene Therapy

Video

The most common form of muscular dystrophy is called Duchenne. The disease is caused by a faulty gene that interferes with how muscle cells produce a protein called dystrophin. It’s part of a vital protein complex that works to strengthen and protect muscle fibers.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE